Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · IEX Real-Time Price · USD
2.490
-0.010 (-0.40%)
At close: Mar 28, 2024, 4:00 PM
2.520
+0.030 (1.20%)
After-hours: Mar 28, 2024, 6:35 PM EDT

Hepion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202220212020201920182017201620152014
Market Capitalization
11238720195283411321
Market Cap Growth
--73.66%339.65%6.77%301.65%-83.64%-15.93%-70.37%451.62%-
Enterprise Value
-8-28-4-2053222610919
PE Ratio
-0.40-0.50-2.66-0.97-1.48-0.26-3.75-1.97-5.10-3.88
PB Ratio
0.670.460.930.491.192.337.6125.4432.90-6.99
P/FCF Ratio
-0.52-0.65-2.77-1.22-2.43-0.29-3.43-2.02-11.60-14.88
P/OCF Ratio
-0.52-0.65-2.78-1.22-2.45-0.29-3.43-2.02-11.70-15.05
EV/EBITDA Ratio
0.000.630.131.00-0.73-0.33-2.35-1.54-4.90-3.55
EV/EBIT Ratio
0.000.630.131.00-0.73-0.33-2.35-1.54-4.89-3.55
EV/FCF Ratio
0.000.810.131.24-0.71-0.21-2.71-1.58-11.13-13.56
Debt / Equity Ratio
0.010.000.000.020.050.73-0.01--
Debt / EBITDA Ratio
-0.010.00-0.01-0.04-0.11-0.15-0.00--
Debt / FCF Ratio
-0.010.00-0.01-0.05-0.11-0.09-0.00--
Quick Ratio
3.016.4911.138.748.650.992.291.462.353.96
Current Ratio
3.327.1611.889.158.941.042.331.552.714.32
Interest Coverage
-4970.96-4434.65-3692.66-649.78-13.32-28.44----406.94
Return on Equity (ROE)
-147.60%-68.90%-30.90%-90.00%-98.80%-801.90%-173.00%-1090.30%-433.70%190.50%
Return on Assets (ROA)
-111.70%-58.60%-28.50%-70.00%-68.50%-179.30%-54.10%-203.80%-357.30%-446.70%
Return on Capital (ROIC)
-291.53%-91.14%-32.58%-48.81%-47.31%-427.35%-284.13%-1566.69%-405.92%57.01%
Earnings Yield
-440.93%-198.05%-37.66%-103.01%-67.42%-388.40%-26.65%-50.71%-19.61%-25.75%
FCF Yield
-338.57%-152.79%-36.08%-82.22%-41.14%-339.45%-29.13%-49.41%-8.62%-6.72%
Buyback Yield / Dilution
-0.70%-8.45%-626.31%-373.65%-1011.18%-33.00%-186.13%-24.41%-69.76%-
Total Shareholder Return
-0.70%-8.45%-626.31%-373.65%-1011.18%-33.00%-186.13%-24.41%-69.76%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).